We are live on ! Find out more
SPC

Slate Path Capital Portfolio holdings

AUM $6.73B
1-Year Est. Return 95.97%
This Fund
S&P 500
This Quarter Est. Return
+26.61%
1 Year Est. Return
+95.97%
3 Year Est. Return
+272.8%
5 Year Est. Return
+330.15%
10 Year Est. Return
+4,591.92%
AUM
$1.86B
AUM Growth
+$346M
Cap. Flow
+$9.81M
Cap. Flow %
0.53%
Top 10 Hldgs %
81.62%
Holding
33
New
4
Increased
6
Reduced
3
Closed
6

Top Buys

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$145M
2
FCX icon
Freeport-McMoran
FCX
+$74.6M
3
EQT icon
EQT Corp
EQT
+$48.6M
4
MOS icon
The Mosaic Company
MOS
+$37.5M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$19.9M

Top Sells

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$192M
2
GE icon
GE Aerospace
GE
+$92.5M
3
CHTR icon
Charter Communications
CHTR
+$40.5M
4
CYCN icon
Cyclerion Therapeutics
CYCN
+$10.7M
5
NYT icon
New York Times
NYT
+$4.81M

Sector Composition

Rank Sector Weight
1 Communication Services 38.95%
2 Materials 28.71%
3 Healthcare 16.76%
4 Industrials 7.2%
5 Energy 3.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENDP
26
DELISTED
Endo International plc
ENDP
$1.64M 0.09%
+350,000
New +$1.56M
X
27
DELISTED
US Steel
X
$456K 0.02%
40,000
– –
CYCN icon
28
Cyclerion Therapeutics
CYCN
$15.2M
– –
-44,000
Closed -$10.7M
GE icon
29
GE Aerospace
GE
$364B
– –
-2,076,589
Closed -$92.5M
PDD icon
30
Pinduoduo
PDD
$126B
– –
-65,000
Closed -$2.09M
QQQ icon
31
CALL
Invesco QQQ Trust
QQQ
$436B
– –
-21,000
Closed -$3.96M
SDRL
32
DELISTED
Seadrill Limited Common Stock
SDRL
– –
-390,000
Closed -$819K
MDR
33
DELISTED
McDermott International
MDR
– –
-290,000
Closed -$586K
1
2

Similar funds

SPS
Susquehanna Portfolio Strategies Bala Cynwyd, Pennsylvania $6.73B AUM 45.57% 1-Year Est. Return
BHM
Briar Hall Management Nashville, Tennessee $6.72B AUM 4.95% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
CIMLRA
CBRE Investment Management Listed Real Assets Radnor, Pennsylvania $6.75B AUM 8.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
MSE
MUFG Securities EMEA London, United Kingdom $6.7B AUM 32.3% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Slate Path Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Slate Path Capital held 33 positions worth $1.86B, up 23% from $1.51B the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Slate Path Capital's Q4 2019 filing shows 4 new, 6 increased, 3 reduced and 6 closed positions. Its largest new stake was Bausch Health: 5,579,948 shares worth $167M. The largest sale was Medicines Co, an estimated $192M.

By sector, the portfolio is most concentrated in Communication Services at 39% of assets, down from 44% a quarter earlier, followed by Materials and Healthcare.

  • Slate Path Capital's largest Q4 2019 buy was Bausch Health: 5,579,948 shares worth $167M.
  • Slate Path Capital added most to Freeport-McMoran in Q4 2019, an estimated $74.6M increase.
  • Slate Path Capital's biggest Q4 2019 reduction was Medicines Co, cutting an estimated $192M.
  • Slate Path Capital fully exited GE Aerospace in Q4 2019, selling an estimated $92.5M.
  • Slate Path Capital's ten largest holdings make up 82% of its $1.86B portfolio in Q4 2019.
  • Slate Path Capital opened 4 new positions and closed 6 in Q4 2019.
  • Slate Path Capital's portfolio value rose 23% quarter-over-quarter to $1.86B.

Based on Slate Path Capital's 13F filing for Q4 2019, filed 14 Feb 2020.